Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sarcoma | 15 | 2020 | 1786 | 1.900 |
Why?
|
Neoplasms, Radiation-Induced | 4 | 2020 | 549 | 1.630 |
Why?
|
HMGA2 Protein | 2 | 2017 | 102 | 1.130 |
Why?
|
Soft Tissue Neoplasms | 7 | 2020 | 1151 | 0.970 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2023 | 28 | 0.910 |
Why?
|
Skin Neoplasms | 7 | 2024 | 5797 | 0.870 |
Why?
|
Polyomavirus Infections | 1 | 2024 | 195 | 0.780 |
Why?
|
Immunohistochemistry | 10 | 2024 | 11064 | 0.770 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2022 | 70 | 0.760 |
Why?
|
Tumor Virus Infections | 1 | 2024 | 438 | 0.740 |
Why?
|
Carcinoma | 3 | 2022 | 2334 | 0.680 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2024 | 321 | 0.680 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2018 | 39 | 0.610 |
Why?
|
SOXE Transcription Factors | 1 | 2018 | 73 | 0.600 |
Why?
|
Melanoma | 6 | 2022 | 5695 | 0.570 |
Why?
|
Adenoma, Pleomorphic | 1 | 2017 | 75 | 0.550 |
Why?
|
Myofibroma | 1 | 2016 | 45 | 0.550 |
Why?
|
Keratins | 1 | 2018 | 497 | 0.540 |
Why?
|
Biopsy, Fine-Needle | 2 | 2018 | 1111 | 0.520 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2020 | 2052 | 0.510 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2020 | 995 | 0.480 |
Why?
|
Neoplasm, Residual | 4 | 2015 | 1008 | 0.460 |
Why?
|
Pericytes | 1 | 2016 | 292 | 0.460 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2017 | 325 | 0.450 |
Why?
|
Salivary Gland Neoplasms | 1 | 2017 | 304 | 0.440 |
Why?
|
Neurilemmoma | 2 | 2020 | 523 | 0.430 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2023 | 1720 | 0.410 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 927 | 0.400 |
Why?
|
Carcinoma, Papillary | 1 | 2017 | 785 | 0.400 |
Why?
|
Histones | 2 | 2020 | 2583 | 0.370 |
Why?
|
Thyroid Gland | 1 | 2017 | 1169 | 0.360 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2009 | 55 | 0.340 |
Why?
|
Sarcoma, Experimental | 3 | 2013 | 118 | 0.320 |
Why?
|
Minor Histocompatibility Antigens | 5 | 2010 | 293 | 0.290 |
Why?
|
Esophageal Neoplasms | 1 | 2017 | 1651 | 0.290 |
Why?
|
MicroRNAs | 5 | 2015 | 3784 | 0.270 |
Why?
|
Neoplasm Invasiveness | 4 | 2021 | 3618 | 0.260 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5333 | 0.260 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1729 | 0.260 |
Why?
|
Fluorescent Dyes | 4 | 2016 | 1914 | 0.250 |
Why?
|
PAX7 Transcription Factor | 2 | 2015 | 55 | 0.240 |
Why?
|
MyoD Protein | 2 | 2015 | 144 | 0.230 |
Why?
|
Merkel Cells | 1 | 2024 | 24 | 0.230 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2332 | 0.230 |
Why?
|
Mutation | 6 | 2023 | 29950 | 0.230 |
Why?
|
DNA Methylation | 1 | 2017 | 4374 | 0.210 |
Why?
|
Ribonuclease III | 2 | 2014 | 279 | 0.190 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2017 | 2500 | 0.190 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2021 | 47 | 0.180 |
Why?
|
Cell Differentiation | 3 | 2018 | 11480 | 0.180 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13249 | 0.180 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6310 | 0.170 |
Why?
|
Neural Crest | 2 | 2021 | 279 | 0.170 |
Why?
|
Zebrafish | 5 | 2022 | 2996 | 0.170 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2022 | 329 | 0.160 |
Why?
|
Laboratories | 1 | 2022 | 461 | 0.160 |
Why?
|
Cytodiagnosis | 1 | 2022 | 432 | 0.160 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2021 | 262 | 0.160 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2020 | 635 | 0.150 |
Why?
|
Mutagenesis | 1 | 2022 | 1234 | 0.150 |
Why?
|
Tretinoin | 1 | 2021 | 519 | 0.150 |
Why?
|
Humans | 39 | 2024 | 760261 | 0.150 |
Why?
|
Methylation | 1 | 2020 | 1080 | 0.150 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2022 | 475 | 0.150 |
Why?
|
DEAD-box RNA Helicases | 2 | 2012 | 383 | 0.150 |
Why?
|
Limit of Detection | 1 | 2018 | 280 | 0.140 |
Why?
|
Genes, Neoplasm | 1 | 2018 | 370 | 0.140 |
Why?
|
Color | 1 | 2018 | 298 | 0.140 |
Why?
|
Hemangiosarcoma | 1 | 2019 | 218 | 0.140 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 12968 | 0.140 |
Why?
|
Carcinoma in Situ | 1 | 2022 | 796 | 0.130 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 679 | 0.130 |
Why?
|
Microscopy, Fluorescence | 2 | 2013 | 2651 | 0.130 |
Why?
|
Salivary Glands | 1 | 2017 | 229 | 0.130 |
Why?
|
Genes, ras | 1 | 2018 | 654 | 0.130 |
Why?
|
Cathepsins | 2 | 2013 | 242 | 0.120 |
Why?
|
Leiomyosarcoma | 1 | 2019 | 424 | 0.120 |
Why?
|
Disease Models, Animal | 8 | 2021 | 18134 | 0.120 |
Why?
|
Melanocytes | 1 | 2018 | 512 | 0.120 |
Why?
|
Zebrafish Proteins | 1 | 2021 | 1006 | 0.120 |
Why?
|
Haploinsufficiency | 2 | 2014 | 329 | 0.120 |
Why?
|
Animals | 22 | 2022 | 167940 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2018 | 1246 | 0.110 |
Why?
|
Diphenylamine | 1 | 2013 | 49 | 0.110 |
Why?
|
Myoblasts, Skeletal | 1 | 2013 | 76 | 0.110 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 538 | 0.110 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1655 | 0.110 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2022 | 2415 | 0.110 |
Why?
|
Neoplastic Stem Cells | 2 | 2013 | 1347 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2021 | 8498 | 0.110 |
Why?
|
Osteosarcoma | 1 | 2019 | 898 | 0.110 |
Why?
|
Peptide Hydrolases | 1 | 2016 | 623 | 0.100 |
Why?
|
Graft vs Leukemia Effect | 2 | 2010 | 121 | 0.100 |
Why?
|
Dog Diseases | 1 | 2013 | 141 | 0.100 |
Why?
|
Societies, Medical | 1 | 2024 | 3903 | 0.100 |
Why?
|
Neurofibromin 1 | 1 | 2013 | 190 | 0.100 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2013 | 167 | 0.100 |
Why?
|
Thyroidectomy | 1 | 2017 | 903 | 0.100 |
Why?
|
Translocation, Genetic | 1 | 2017 | 1388 | 0.100 |
Why?
|
Esophagus | 1 | 2017 | 1023 | 0.100 |
Why?
|
Lighting | 1 | 2013 | 211 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 6545 | 0.090 |
Why?
|
Diagnostic Imaging | 2 | 2016 | 3526 | 0.090 |
Why?
|
Intraoperative Period | 1 | 2012 | 516 | 0.090 |
Why?
|
Rhabdomyosarcoma | 1 | 2013 | 361 | 0.090 |
Why?
|
Infrared Rays | 1 | 2012 | 246 | 0.090 |
Why?
|
Leukemia | 2 | 2010 | 1522 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 642 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 1 | 2022 | 4494 | 0.090 |
Why?
|
Prognosis | 3 | 2020 | 29636 | 0.090 |
Why?
|
Mice | 13 | 2016 | 81216 | 0.090 |
Why?
|
Aged | 5 | 2024 | 168995 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20048 | 0.080 |
Why?
|
Lymphoma | 1 | 2019 | 1899 | 0.080 |
Why?
|
Heterocyclic Compounds | 1 | 2010 | 247 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2022 | 9274 | 0.080 |
Why?
|
MAP Kinase Signaling System | 2 | 2013 | 1483 | 0.080 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58947 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5230 | 0.080 |
Why?
|
H-Y Antigen | 1 | 2008 | 42 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2874 | 0.080 |
Why?
|
Survival Rate | 2 | 2020 | 12806 | 0.080 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 2010 | 1765 | 0.080 |
Why?
|
Muscle, Skeletal | 2 | 2013 | 4923 | 0.080 |
Why?
|
Adult | 7 | 2024 | 219847 | 0.070 |
Why?
|
Gene Deletion | 4 | 2018 | 2668 | 0.070 |
Why?
|
Young Adult | 4 | 2019 | 58673 | 0.070 |
Why?
|
Stromal Cells | 1 | 2013 | 1327 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2017 | 2823 | 0.070 |
Why?
|
Benzamides | 1 | 2013 | 1369 | 0.070 |
Why?
|
Middle Aged | 7 | 2019 | 220175 | 0.070 |
Why?
|
Genes, p53 | 1 | 2009 | 714 | 0.070 |
Why?
|
Protein Splicing | 1 | 2006 | 16 | 0.070 |
Why?
|
Microarray Analysis | 1 | 2009 | 747 | 0.070 |
Why?
|
Neoplasm Metastasis | 3 | 2015 | 4891 | 0.070 |
Why?
|
Minor Histocompatibility Loci | 1 | 2006 | 16 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2013 | 817 | 0.070 |
Why?
|
Female | 11 | 2024 | 391011 | 0.060 |
Why?
|
Survival Analysis | 1 | 2018 | 10185 | 0.060 |
Why?
|
Male | 10 | 2024 | 359413 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2014 | 1892 | 0.060 |
Why?
|
Receptors, CXCR4 | 1 | 2010 | 728 | 0.060 |
Why?
|
Species Specificity | 1 | 2009 | 2413 | 0.060 |
Why?
|
Biopsy | 1 | 2017 | 6775 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4875 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14656 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2018 | 7854 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2018 | 10434 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2010 | 5644 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2013 | 2909 | 0.060 |
Why?
|
Genomics | 3 | 2022 | 5790 | 0.060 |
Why?
|
Surgery, Computer-Assisted | 1 | 2012 | 1007 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2532 | 0.050 |
Why?
|
Transcription Factors | 2 | 2021 | 12100 | 0.050 |
Why?
|
Muscle Development | 2 | 2015 | 261 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11141 | 0.050 |
Why?
|
HLA-A Antigens | 3 | 2008 | 225 | 0.050 |
Why?
|
Injections, Intravenous | 2 | 2016 | 1388 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8621 | 0.050 |
Why?
|
Peritoneal Cavity | 1 | 2022 | 142 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15273 | 0.050 |
Why?
|
Cell Line, Tumor | 5 | 2021 | 16905 | 0.050 |
Why?
|
Genome | 1 | 2009 | 1739 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2008 | 1354 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2006 | 5793 | 0.050 |
Why?
|
Neoplasms | 2 | 2023 | 22066 | 0.050 |
Why?
|
Radiation | 1 | 2020 | 48 | 0.050 |
Why?
|
Pathology | 1 | 2024 | 270 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2006 | 1254 | 0.050 |
Why?
|
Neurofibrosarcoma | 1 | 2020 | 26 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16543 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2008 | 1999 | 0.040 |
Why?
|
Tissue Distribution | 2 | 2016 | 2262 | 0.040 |
Why?
|
Incidence | 1 | 2018 | 21378 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2024 | 361 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7468 | 0.040 |
Why?
|
Mice, Nude | 2 | 2015 | 3605 | 0.040 |
Why?
|
Time Factors | 3 | 2018 | 40133 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2008 | 4554 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 1 | 2010 | 3390 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9590 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2021 | 64947 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2014 | 9531 | 0.040 |
Why?
|
Minority Groups | 1 | 2024 | 1199 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17766 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 17628 | 0.030 |
Why?
|
Benchmarking | 1 | 2022 | 1043 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 11341 | 0.030 |
Why?
|
B-Lymphocytes | 2 | 2006 | 4739 | 0.030 |
Why?
|
Disease Progression | 1 | 2012 | 13505 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 562 | 0.030 |
Why?
|
Mucous Membrane | 1 | 2018 | 657 | 0.030 |
Why?
|
Chromatography | 1 | 2014 | 189 | 0.030 |
Why?
|
Genotype | 1 | 2009 | 12959 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2018 | 516 | 0.030 |
Why?
|
Base Sequence | 3 | 2014 | 12447 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2018 | 729 | 0.030 |
Why?
|
United States | 2 | 2024 | 72363 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2010 | 1351 | 0.030 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2006 | 1628 | 0.030 |
Why?
|
Cell Fractionation | 1 | 2014 | 251 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2019 | 21065 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 1617 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2014 | 402 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9388 | 0.030 |
Why?
|
RNA Precursors | 1 | 2014 | 212 | 0.030 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2013 | 74 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2018 | 1553 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2008 | 3217 | 0.030 |
Why?
|
Cell Movement | 2 | 2015 | 5206 | 0.030 |
Why?
|
RNA Stability | 1 | 2014 | 332 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10183 | 0.030 |
Why?
|
Whole-Body Irradiation | 1 | 2013 | 433 | 0.020 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2014 | 414 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2866 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2008 | 4312 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2015 | 768 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2023 | 3618 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2013 | 5873 | 0.020 |
Why?
|
Hindlimb | 1 | 2013 | 510 | 0.020 |
Why?
|
Curriculum | 1 | 2024 | 3722 | 0.020 |
Why?
|
Fluorescence | 1 | 2013 | 750 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13629 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2019 | 80301 | 0.020 |
Why?
|
Alleles | 2 | 2014 | 6900 | 0.020 |
Why?
|
Benzylamines | 1 | 2010 | 248 | 0.020 |
Why?
|
Microvessels | 1 | 2013 | 572 | 0.020 |
Why?
|
Metabolome | 1 | 2016 | 976 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2014 | 933 | 0.020 |
Why?
|
Dermis | 1 | 2010 | 202 | 0.020 |
Why?
|
Karyotyping | 1 | 2010 | 1172 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3105 | 0.020 |
Why?
|
Child | 1 | 2016 | 79758 | 0.020 |
Why?
|
Adolescent | 1 | 2016 | 87747 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2018 | 2895 | 0.020 |
Why?
|
HLA-A2 Antigen | 1 | 2008 | 211 | 0.020 |
Why?
|
Dogs | 1 | 2013 | 3843 | 0.020 |
Why?
|
Down-Regulation | 1 | 2015 | 2918 | 0.020 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 938 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2015 | 8945 | 0.020 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2008 | 347 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2010 | 825 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1972 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 1705 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1726 | 0.020 |
Why?
|
HLA-A3 Antigen | 1 | 2006 | 34 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 22025 | 0.020 |
Why?
|
Gene Library | 1 | 2008 | 1060 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5039 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2006 | 871 | 0.020 |
Why?
|
Electroporation | 1 | 2006 | 256 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2013 | 2510 | 0.010 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2006 | 267 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2008 | 825 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 13456 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5784 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2006 | 929 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2013 | 2927 | 0.010 |
Why?
|
Antigens, CD19 | 1 | 2006 | 414 | 0.010 |
Why?
|
Mice, SCID | 1 | 2008 | 2627 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1737 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4573 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2006 | 1091 | 0.010 |
Why?
|
Transfection | 1 | 2008 | 5782 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11708 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2006 | 1314 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 4814 | 0.010 |
Why?
|
Myelodysplastic Syndromes | 1 | 2010 | 1401 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2378 | 0.010 |
Why?
|
Fibroblasts | 1 | 2010 | 4091 | 0.010 |
Why?
|
Epitopes | 1 | 2006 | 2506 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39254 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2006 | 3160 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2008 | 15766 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2010 | 3023 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23363 | 0.010 |
Why?
|
Cytokines | 1 | 2010 | 7345 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2006 | 5498 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2006 | 3448 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2006 | 5120 | 0.010 |
Why?
|
Gene Expression | 1 | 2006 | 7592 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 13967 | 0.010 |
Why?
|
DNA | 1 | 2006 | 7236 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 54263 | 0.010 |
Why?
|